C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
12/2004
12/23/2004	WO2004085409A3 Compounds and libraries of pyridines, pyrazines, imidazo[1,2-a]pyrazines and 1h-imidazo[4,5-b]pyrazin-2-ones and first and second medical uses thereof
12/23/2004	WO2004078128A3 Substituted pyridine derivatives useful in the treatment of cancer and other disorders
12/23/2004	WO2003095438A9 Substituted phenylacetamides and their use as glucokinase activators
12/23/2004	WO2003093250A3 Positive allosteric modulators of the nicotinic acetylcholine receptor
12/23/2004	US20040260088 Novel compounds
12/23/2004	US20040259950 Dicarboxy compounds for use as drugs and receptors for proliferation
12/23/2004	US20040259916 N-[4-(cyanocyclobutyl)-phenyl]{2-[(4-pyridylmethyl)amino]phenyl}carboxamidefor example; inhibit the effect of VEGF receptor tyrosine kinase; use treating cancer, diabetes, and angiogenesis
12/23/2004	US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence
12/23/2004	US20040259908 Integrin VLA-4 ( alpha 4 beta 1) and/or integrin LPAM-1 ( alpha 4 beta 7) antagonists, cell adhesion inhibitor; bioavailability, oral administration;treating inflammatory diseases; e.g. 3-[2-(2,6-dichlorobenzoylamino)pyrid-5-yl]-2-{3-[(2,2-dimethylpropionyl)isobutylamino]-4-methoxyphenyl}propionic acid
12/23/2004	US20040259877 Inhibitors against the production and release of inflammatory cytokines
12/23/2004	US20040259869 Cycloalkyl alkanoic acids as integrin receptor antagonists
12/23/2004	US20040259823 Cationic amphiphiles as transfection vehicles
12/23/2004	US20040259804 (Substituted)Acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases
12/23/2004	DE10325133A1 Triazolopyrimidine Triazolopyrimidines
12/23/2004	CA2528993A1 Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
12/23/2004	CA2528231A1 New benzamides as ppar.gamma. modulators
12/23/2004	CA2527586A1 Pyridine n-oxides as antiviral agents
12/23/2004	CA2527236A1 Thiotungstate analogues and uses thereof
12/23/2004	CA2526518A1 1-aryl-4-(aryloxycarbonyl)-piperazine derivatives for use as inhibitors of hormone sensitive lipase
12/23/2004	CA2526387A1 Benzamide derivative or salt thereof
12/23/2004	CA2526204A1 Pyridinyl carbamates as hormone-sensitive lipase inhibitors
12/23/2004	CA2526041A1 Anthranylamide pyridones that inhibit vegfr-2 and vegfr-3
12/22/2004	EP1489418A1 Novel fluorescent label compounds
12/22/2004	EP1489070A1 Process for production of optically active compounds
12/22/2004	EP1489068A1 Multidentate ligand, multi-nucleus metal complex, metal complex chain, metal complex integrated structure, and preparation method thereof
12/22/2004	EP1488792A2 Quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
12/22/2004	EP1487922A1 Azo dyes
12/22/2004	EP1487794A1 Monocyclic aroylpyridinones as antiinflammatory agents
12/22/2004	EP1487785A2 Novel florfenicol-type antibiotics
12/22/2004	EP1487779A1 Oligofluorenylene compounds
12/22/2004	EP1487776A1 Acid and ester compounds and methods of using the same
12/22/2004	EP1487428A2 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
12/22/2004	EP1305346B1 Transformation of polymers to useful chemicals by oxidation
12/22/2004	EP1161555A4 4-(4-hydroxystyryl)pyridine-containing substrates for an analyte dependent enzyme activation system
12/22/2004	EP1086076B1 Sulfonamide inhibitors of aspartyl protease
12/22/2004	EP0927030B1 Use of aryl n-substituted carboxamides to kill tumors
12/22/2004	EP0872477B1 Naphthol derivative and process for preparing the same
12/22/2004	CN1556809A Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives
12/22/2004	CN1556788A Muscarinic agonists
12/22/2004	CN1181077C Ion liquid
12/22/2004	CN1181058C Prepn process of pyrido-phenylurea
12/22/2004	CN1181055C Alanine class compound, its preparing method and use
12/21/2004	US6833379 As diuretic agent
12/21/2004	US6833378 Pyridines, pyrimidines, purinones, pyrrolopyrimidinones and pyrrolopyridinones; useful in the treatment disorders including CNS and stress-related disorders.
12/21/2004	US6833369 Treatment of ocular neovascular diseases, neovascular glaucoma, diabetic retinopathy,
12/21/2004	US6833366 Alpha v beta 3 and/or 5 integrin antagonists; reduced side effects
12/21/2004	US6833200 Luminescent device with a triarylamine compound
12/21/2004	US6833140 Orally administered dosage forms of GABA analog prodrugs having reduced toxicity
12/21/2004	CA2317604C Matrix metalloprotease inhibitors
12/21/2004	CA2241904C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
12/16/2004	WO2004108857A1 Organic electroluminescent devices and metal complex compounds
12/16/2004	WO2004108727A1 Triazolopyrimidines
12/16/2004	WO2004108719A1 2-[2-(4-morpholino)ethylamino]pyridine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same
12/16/2004	WO2004108684A1 Novel azole derivative having antifungal activity
12/16/2004	WO2004108676A1 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamine derivatives as beta 2-adrenoceptors agonists
12/16/2004	WO2004108675A1 2-amino-pyridine derivatives as beta-2 adrenoreceptor agonists
12/16/2004	WO2004108663A1 N-alkynyl-2- (substituted aryloxy) alkylthioamide derivatives as fungicides
12/16/2004	WO2004108654A1 Chain lactic acid oligomer derivative and process for producing the same
12/16/2004	WO2004078136A3 Pyridinium salts, compounds and methods of use
12/16/2004	WO2004037789A8 Methylene urea derivatives as raf-kinase inhibitors
12/16/2004	WO2003063797A8 Cycloalkyl inhibitors of potassium channel function
12/16/2004	WO2002076177A3 Design and synthesis of optimized ligands for ppar
12/16/2004	US20040254379 Process for the production of heteroaromatic nitriles improved catalyst therefor and a process for the production of said improved catalyst
12/16/2004	US20040254378 2-Methanesulfone group; Side effect reduction; Nonsteroidal Antiinflammatory
12/16/2004	US20040254376 Cyclic amidine derivative
12/16/2004	US20040254373 Positive allosteric modulators of the nicotinic acetylcholine receptor
12/16/2004	US20040254344 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
12/16/2004	US20040254237 Acid amide derivatives, process for producing these, and pest agent containing these
12/16/2004	US20040254223 Process for the preparation of amorphous form of torsemide
12/16/2004	US20040254185 Endothelial growth factor antagonist; angiogenesis inhibitor; skin disorders; anticancer agents; endometriosis; Crohn's disease; leukemia; antiarthritic agents; vision defects
12/16/2004	US20040254182 Enhanced propertied pharmaceuticals
12/16/2004	US20040254166 Substituted phenyl acetamides and their use as protease inhibitors
12/16/2004	US20040254163 New analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
12/16/2004	US20040254158 1,1-Disubstituted cycloalkyl derivatives as factor Xa inhibitors
12/16/2004	US20040254147 Using hexafluorophosphate salt of pyridinium, imidazolium compound
12/16/2004	US20040253194 Pyrithione biocides enhanced by zinc metal ions and organic amines
12/16/2004	US20040252171 Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method
12/16/2004	CA2527788A1 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamine derivatives as beta 2-adrenoceptors agonists
12/16/2004	CA2527334A1 2-amino-pyridine derivatives as beta-2 adrenoreceptor agonists
12/16/2004	CA2527313A1 N-alkynyl-2-(substituted aryloxy) alkylthioamide derivatives as fungicides
12/15/2004	EP1486526A1 Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method
12/15/2004	EP1486489A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
12/15/2004	EP1486488A1 Use of a compound of formula I for making a pharmaceutical composition
12/15/2004	EP1486486A2 Substituted B-thiocarboxylic acids
12/15/2004	EP1486207A2 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
12/15/2004	EP1485387A1 Carbamates as hiv protease inhibitors
12/15/2004	EP1485386A2 Pyridinyloxy derivatives as 5-ht receptor ligands
12/15/2004	EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485365A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485355A2 Pyridinyl amides and compositions thereof for use as fungicides
12/15/2004	EP1485353A1 New inhibitors of histone deacetylase
12/15/2004	EP1485348A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485131A1 Matrix metalloproteinase inhibitors in combination with hypothermia and/or radiotherapy for the treatment of cancer
12/15/2004	EP1485099A1 Inhibitors of histone deacetylase
12/15/2004	EP1485089A1 Combination treatments for chemokine-mediated diseases
12/15/2004	EP1485079A2 Small molecule entry inhibitors
12/15/2004	EP1361851A4 Primary intermediates for oxidative coloration of hair
12/15/2004	EP1359892A4 Primary intermediates for oxidative coloration of hair
12/15/2004	EP1263711B1 Novel use of phenylheteroalkylamine derivatives

1 ... 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 ... 633